Clinical Trials Logo
  1. Home
  2. Kidney Transplantation
  3. NCT04377776
  4. Details
NCT04377776 Clinical Trial

Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients

Kidney Transplant Clinical Trial

Official title:
Observational Study to Assess the Health Status of Transplanted Patients (Kidney or Pancreas or Pancreatic Islet Transplantation) at Transplant Medicine Unit (MITRA) During the COVID-19 Pandemic

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04377776
Other study ID # COVID-19 MITRA
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 4, 2020
Est. completion date May 18, 2020

Study information
Verified date June 2020
Source IRCCS San Raffaele
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Collect informations on the health status of transplanted patients (kidney, kidney / pancreas, pancreas or pancreatic islet) during the COVID-19 pandemic. All informations will be collected by short questionnaire via phone.

Recruitment information / eligibility
Status Completed
Enrollment 644
Est. completion date May 18, 2020
Est. primary completion date May 18, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

Transplanted Kidney or Kidney/Pancreas or Pancreas or Pancreatic Islet patients at Transplant Medicine Unit - San Raffaele Scientif Institute

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Practice details
Questionnaire

Locations
Country Name City State
Italy IRCCS San Raffaele Milano

Sponsors (1)
Lead Sponsor Collaborator
IRCCS San Raffaele

Country where clinical trial is conducted

Italy, 

Outcome
Type Measure Description Time frame Safety issue
Primary Global Prevalence of COVID-19 TX Global Prevalence of COVD-19 infection in transplanted patients From 01st February 2020 to 18 May 2020
Primary Hospitalization rate in COVID-19 TX Hospitalization rate of transplanted patients From 01st February 2020 to 18 May 2020
Secondary Correlation COVID-19 TX and type of transplantation Correlation between type of transplantation to COVID-19 virus infection From 01st February 2020 to 18 May 2020
Secondary Prevalence of COVID-19 TX in italian provinces Prevalence COVID-19 virus infection in transplanted patients in italian provinces From 01st February 2020 to 18 May 2020
Secondary Symptoms in COVID-19 TX Prevalence of different symptoms in COVID-19 virus infection in transplanted patients From 01st February 2020 to 18 May 2020
Secondary Correlation COVID-19 TX and comorbidities Correlation between comorbidities to COVID-19 virus infection From 01st February 2020 to 18 May 2020
Secondary COVID-19 TX Therapies Impact of different therapies on COVID-19 virus infection in transplanted patients From 01st February 2020 to 18 May 2020
Secondary COVID-19 TX in family settings Impact of COVID-19 virus infection in transplanted patients family settings From 01st February 2020 to 18 May 2020
See also
  Status Clinical Trial Phase
Completed NCT04087720 - Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant Phase 4
Completed NCT03749356 - Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients Phase 4
Withdrawn NCT05811468 - Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kidney Transplant Recipients
Completed NCT03527238 - Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine Phase 2
Completed NCT00498576 - Melatonin and Adiponectin in Hypertensive Kidney Transplant N/A
Completed NCT00642655 - Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation Phase 1/Phase 2
Completed NCT00374400 - The Paired Donation Consortium Paired Donation Program N/A
Completed NCT01710033 - A Study Of CP-690,550 In Stable Kidney Transplant Patients Phase 1
Completed NCT00205257 - Prediction of Acute Rejection in Renal Transplant Phase 1
Completed NCT02711826 - Treg Therapy in Subclinical Inflammation in Kidney Transplantation Phase 1/Phase 2
Withdrawn NCT03978494 - Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients. Phase 1
Completed NCT03837522 - Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies N/A
Not yet recruiting NCT06025240 - Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Completed NCT05029310 - Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients Phase 4
Completed NCT03644485 - Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients Phase 4
Active, not recruiting NCT02409901 - Effects of Personalized Physical Rehabilitation in Kidney Transplant Recipients N/A
Completed NCT01047410 - ACtive Care After Transplantation, the ACT Study N/A
Completed NCT00940940 - Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation Phase 4
Completed NCT00217126 - The Study of Long-term Deterioration of Kidney Transplants. Phase 4
Completed NCT00270712 - A Study of Factors That Affect Long-Term Kidney Transplant Function